CONTRACT MANUFACTURING AGREEMENT

Contract No.: CMA-2025-0219
Effective Date: July 14, 2025

This Contract Manufacturing Agreement ("Agreement") is entered into by and between:

BRAND OWNER: Solaris Personal Care, Inc., a New York corporation, with its principal office at 350 Fifth Avenue, Suite 4200, New York, NY 10118 ("Brand Owner")

CONTRACT MANUFACTURER: Pacific Coast Labs, LLC, a California limited liability company, with its manufacturing facility at 14200 East Valley Boulevard, Industry, CA 91746 ("Manufacturer")

RECITALS

WHEREAS, Brand Owner develops, markets, and sells premium personal care products under various proprietary brand names; and

WHEREAS, Manufacturer operates FDA-registered facilities and possesses the technical expertise, equipment, and capacity to manufacture personal care products; and

WHEREAS, Brand Owner desires to engage Manufacturer to manufacture certain products in accordance with Brand Owner's formulations and specifications;

NOW, THEREFORE, the Parties agree as follows:

ARTICLE 1 - DEFINITIONS

1.1 "Products" means the personal care products described in Exhibit A, including skincare serums, moisturizers, cleansers, and hair care treatments.

1.2 "Formulations" means Brand Owner's proprietary formulas, ingredient lists, processing instructions, and related technical documents for each Product.

1.3 "Specifications" means the detailed product specifications, quality parameters, packaging requirements, and labeling instructions set forth in Exhibit B.

1.4 "Batch" means a specific quantity of a single Product manufactured in one production run according to a single Batch Record.

1.5 "Batch Record" means the complete documentation of the manufacturing process for each Batch, including ingredient quantities, processing parameters, in-process testing results, and quality release data.

ARTICLE 2 - ENGAGEMENT AND SCOPE

2.1 Engagement. Brand Owner hereby engages Manufacturer as a non-exclusive contract manufacturer to produce the Products in accordance with the Formulations and Specifications. Manufacturer accepts such engagement.

2.2 Scope of Services. Manufacturer shall:
    (a) Procure raw materials and packaging components as specified by Brand Owner;
    (b) Manufacture the Products in accordance with the Formulations and Specifications;
    (c) Perform quality control testing as specified in the Quality Agreement (Exhibit C);
    (d) Package and label Products in accordance with the Specifications;
    (e) Store finished Products in appropriate conditions pending shipment; and
    (f) Ship Products to Brand Owner's designated locations.

2.3 Exclusions. This Agreement does not cover product development, clinical testing, regulatory submissions, or marketing activities, which shall remain the responsibility of Brand Owner.

ARTICLE 3 - FORMULATIONS AND INTELLECTUAL PROPERTY

3.1 Ownership. All Formulations, trade secrets, trademarks, and intellectual property associated with the Products are and shall remain the sole and exclusive property of Brand Owner.

3.2 Confidentiality of Formulations. Manufacturer shall treat all Formulations as strictly confidential. Access to Formulations shall be limited to Manufacturer personnel with a need to know, and Manufacturer shall maintain a log of all individuals who have accessed the Formulations.

3.3 Non-Compete. During the Term and for two (2) years thereafter, Manufacturer shall not manufacture products that are substantially similar to the Products for any third party, unless such products are based on publicly available formulations or Manufacturer's own pre-existing technology.

3.4 Return of Materials. Upon termination of this Agreement, Manufacturer shall return or destroy all copies of the Formulations and certify such return or destruction in writing.

ARTICLE 4 - ORDERING AND PRODUCTION

4.1 Forecasts. Brand Owner shall provide Manufacturer with a rolling twelve (12) month production forecast, updated quarterly. The first quarter of each forecast shall be binding.

4.2 Purchase Orders. Brand Owner shall issue purchase orders at least forty-five (45) days prior to the requested delivery date. Each purchase order shall specify the Products, quantities, delivery dates, and shipping instructions.

4.3 Minimum Order Quantities. The minimum order quantity for each Product is set forth in Exhibit A. Brand Owner shall not issue purchase orders below the stated minimums without Manufacturer's prior agreement.

4.4 Production Planning. Manufacturer shall schedule production to meet the delivery dates specified in purchase orders and shall notify Brand Owner promptly of any anticipated delays.

4.5 Capacity Reservation. Manufacturer shall reserve adequate production capacity to fulfill Brand Owner's forecasted requirements. If Manufacturer is unable to meet Brand Owner's requirements due to capacity constraints, Manufacturer shall provide at least sixty (60) days' advance notice.

ARTICLE 5 - RAW MATERIALS AND COMPONENTS

5.1 Procurement. Manufacturer shall procure all raw materials and packaging components required for the manufacture of Products from suppliers approved by Brand Owner ("Approved Suppliers"). Manufacturer shall not substitute materials or suppliers without Brand Owner's prior written approval.

5.2 Incoming Inspection. Manufacturer shall inspect and test all incoming raw materials in accordance with the specifications and testing protocols provided by Brand Owner. Materials failing to meet specifications shall be rejected and quarantined.

5.3 Material Safety Stock. Manufacturer shall maintain a safety stock of critical raw materials sufficient for at least four (4) weeks of forecasted production.

5.4 Brand Owner-Supplied Materials. Brand Owner may elect to supply certain raw materials or packaging components directly to Manufacturer ("Consigned Materials"). Title to Consigned Materials shall remain with Brand Owner, and Manufacturer shall segregate and account for such materials separately.

ARTICLE 6 - QUALITY ASSURANCE

6.1 Quality Agreement. The Parties shall execute and maintain a Quality Agreement (Exhibit C) that defines quality standards, testing requirements, acceptance criteria, and the responsibilities of each Party.

6.2 Manufacturing Standards. Manufacturer shall manufacture all Products in compliance with current Good Manufacturing Practices (cGMP) as defined by the FDA for cosmetic and personal care products, and in accordance with ISO 22716 standards.

6.3 Testing and Release. Each Batch shall undergo quality control testing as specified in the Quality Agreement before release for shipment. Manufacturer shall not ship any Batch that has not been formally released by Manufacturer's Quality Assurance department.

6.4 Stability Testing. Manufacturer shall conduct ongoing stability testing of Products as specified in the Quality Agreement and shall promptly notify Brand Owner of any adverse stability results.

6.5 Facility Audits. Brand Owner shall have the right to audit Manufacturer's facilities, records, and quality systems at any time upon reasonable advance notice. Manufacturer shall cooperate fully with such audits.

6.6 Regulatory Inspections. Manufacturer shall promptly notify Brand Owner of any regulatory inspection of its facility and shall provide Brand Owner with copies of any inspection reports, warning letters, or other regulatory correspondence related to the Products or the manufacturing facility.

ARTICLE 7 - PRICING AND PAYMENT

[ANOMALY: Contradictory payment terms and missing liability provisions]
7.1 Pricing. The manufacturing prices for Products are set forth in Exhibit A. Prices include raw materials, manufacturing labor, quality testing, standard packaging, and storage for up to thirty (30) days after production.

7.2 Price Adjustments. Manufacturer may request price adjustments annually, supported by documented cost changes. Price increases exceeding three percent (3%) per annum require Brand Owner's written consent.

7.3 Payment Terms. Brand Owner shall pay all invoices within Net-30 days of receipt of a conforming invoice. Manufacturer shall invoice upon shipment of Products.

7.4 Advance Payment. Notwithstanding Section 7.3, for purchase orders exceeding Two Hundred Fifty Thousand Dollars ($250,000), Brand Owner shall remit fifty percent (50%) of the order value as an advance payment upon placement of the purchase order. The remaining balance shall be payable within Net-60 days of delivery.

7.5 Tooling and Setup Charges. Any new tooling, molds, or setup costs required for the manufacture of Products shall be quoted separately and approved by Brand Owner in writing prior to incurrence.

ARTICLE 8 - DELIVERY AND SHIPPING

8.1 Delivery. Manufacturer shall deliver finished Products FCA (Incoterms 2020) Manufacturer's facility. Title and risk of loss shall pass to Brand Owner upon delivery to the carrier.

8.2 Shipping Documentation. Each shipment shall include: (a) packing list; (b) Certificate of Analysis for each Batch; (c) Certificate of Conformance; and (d) Material Safety Data Sheets as applicable.

8.3 On-Time Delivery. Manufacturer shall deliver Products within five (5) business days of the scheduled delivery date. Manufacturer's on-time delivery performance shall be measured monthly, with a target of ninety-five percent (95%).

ARTICLE 9 - WARRANTIES

[ANOMALY: No warranty provided - missing standard provisions]
9.1 Compliance Warranty. Manufacturer warrants that all manufacturing activities shall be conducted in compliance with applicable laws and regulations.

9.2 EXCEPT AS EXPRESSLY SET FORTH IN SECTION 9.1, MANUFACTURER MAKES NO WARRANTIES, EXPRESS OR IMPLIED, INCLUDING WITHOUT LIMITATION ANY WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, OR NON-INFRINGEMENT. BRAND OWNER ASSUMES ALL RISK REGARDING THE SUITABILITY, EFFICACY, AND SAFETY OF THE PRODUCT FORMULATIONS.

ARTICLE 10 - INDEMNIFICATION

10.1 Manufacturer's Indemnification. Manufacturer shall indemnify Brand Owner against claims arising from Manufacturer's negligence, willful misconduct, or failure to comply with manufacturing standards.

10.2 Brand Owner's Indemnification. Brand Owner shall indemnify Manufacturer against claims arising from: (a) the Formulations themselves, including product liability claims related to product design or formulation; (b) Brand Owner's marketing claims; or (c) intellectual property infringement related to the Products.

[ANOMALY: No liability cap specified anywhere in the agreement]

ARTICLE 11 - TERM AND TERMINATION

11.1 Term. This Agreement shall commence on the Effective Date and continue for four (4) years (the "Initial Term"). Thereafter, this Agreement shall renew automatically for successive one (1) year terms.

11.2 Termination for Cause. Either Party may terminate upon sixty (60) days' written notice for material breach that remains uncured.

11.3 Termination for Convenience. Either Party may terminate upon one hundred eighty (180) days' written notice.

11.4 Effects of Termination. Upon termination: (a) Manufacturer shall complete all purchase orders in progress unless otherwise directed; (b) Brand Owner shall pay for all Products manufactured and all non-cancellable raw materials; (c) Manufacturer shall return all Formulations and Consigned Materials; and (d) Manufacturer shall cooperate in an orderly transition to an alternative manufacturer.

ARTICLE 12 - INSURANCE

12.1 Manufacturer shall maintain: (a) CGL of $5,000,000 per occurrence; (b) Products/Completed Operations of $5,000,000; (c) Professional Liability of $2,000,000; and (d) Workers' Compensation as required by law.

ARTICLE 13 - GENERAL PROVISIONS

13.1 Governing Law. This Agreement shall be governed by the laws of the State of New York.

13.2 Dispute Resolution. Disputes shall first be escalated to senior management of both Parties. If unresolved within thirty (30) days, disputes shall be submitted to binding arbitration in New York City under AAA rules.

13.3 Force Majeure. Neither Party shall be liable for performance failures due to events beyond its reasonable control.

13.4 Assignment. Neither Party may assign without the other's written consent, except to an affiliate.

13.5 Entire Agreement. This Agreement, including all Exhibits, constitutes the entire agreement between the Parties.

13.6 Amendments. Amendments must be in writing and signed by both Parties.

13.7 Notices. All notices shall be in writing, delivered to the addresses above.

13.8 Counterparts. This Agreement may be executed in counterparts.

IN WITNESS WHEREOF:

SOLARIS PERSONAL CARE, INC.

By: ___________________________
Name: Elizabeth A. Marchetti
Title: COO
Date: July 14, 2025

PACIFIC COAST LABS, LLC

By: ___________________________
Name: Henry T. Nakamura
Title: General Manager
Date: July 14, 2025

EXHIBIT A - PRODUCTS, PRICING, AND MINIMUM ORDER QUANTITIES
[To be attached]

EXHIBIT B - SPECIFICATIONS
[To be attached]

EXHIBIT C - QUALITY AGREEMENT
[To be attached]
